A similar analysis of the available literature suggests that the majority of other sarcoma types are also associated with low frequencies of TP53 mutations, ranging from approximately 6% in well-differentiated/dedifferentiated liposarcomas to 23% in osteosarcomas (Table 2). This evidence concerns the gene TP53 and liposarcoma.